[Arteriosclerotic risk factors and benign prostatic hyperplasia]

Area of Science:

• Urology
• Cardiovascular Medicine
• Endocrinology

Context:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men.
• Arteriosclerotic risk factors are increasingly recognized for their systemic impact.
• Understanding the link between these factors and BPH is crucial for comprehensive patient care.

Purpose:

• To investigate the association between common arteriosclerotic risk factors and the clinical severity of benign prostatic hyperplasia (BPH).
• To identify specific risk factors that predict prostate enlargement, symptom severity, and bladder outlet obstruction.

Summary:

• This study analyzed 877 BPH patients, assessing prostate volume, obstruction, and symptoms against risk factors like age, hypertension, dyslipidemia, diabetes, and smoking.
• Results indicate a strong correlation between arteriosclerotic risk factors and BPH severity.
• Type 2 diabetes mellitus emerged as a significant predictor for prostate volume, International Prostate Symptom Score (IPSS), and obstruction (OR > 2.8, P < 0.001).
• Age, hypertension, high LDL, low HDL, and smoking also significantly predicted BPH severity.

Impact:

• Highlights the critical role of managing arteriosclerotic risk factors in mitigating BPH progression.
• Identifies type 2 diabetes mellitus as a key factor influencing BPH severity, guiding clinical focus.
• Provides evidence for a multifactorial approach to BPH management, integrating cardiovascular and metabolic health.